Dz13 induces a cytotoxic stress response with upregulation of E2F1 in tumor cells metastasizing to or from bone

Oligonucleotides

Volumn 20, Issue 2, 2010, Pages 79-91

  Dass, Crispin R ^a   Tan, Mei Lin ^a,b   Galloway, Stuart J ^a   Choong, Peter F M ^a,b,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CASPASE 2; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CRADD PROTEIN; DEOXYRIBOZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGONUCLEOTIDE DZ13; OSTEOCALCIN; OSTEOPONTIN; PIDD PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GENE THERAPY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR REGRESSION; UPREGULATION;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; DNA DAMAGE; DNA, CATALYTIC; E2F1 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; UP-REGULATION;

EID: 77951956667     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0224     Document Type: Article

References (63)

1. ANGELUCCI, A., GRAVINA, G.L., RUCCI, N., FESTUCCIA, C., MUZI, P., VICENTINI, C., TETI, A., and BOLOGNA, M. (2004). Evaluation of metastatic potential in prostate carcinoma: an in vivo model. Int. J. Oncol. 25, 1713-1720.
2. BERLIN, O., SAMID, D., DONTHINENI-RAO, R., AKESON, W., AMIEL, D., and WOODS, V.L., Jr. (1993). Development of a novel spontaneous metastasis model of human OS transplanted orthotopically into bone of athymic mice. Cancer Res. 53, 4890-4895.
3. BRUERA, E., and SWEENEY, C. (2003). Bone pain. In: BRUERA, E., and PORTENOY, R.K. (eds.). Cancer pain assessment and management. Cambridge University Press, Cambridge, 515-534.
4. CHEHAB, N.H., MALIKZAY, A., APPEL, M., and HALAZONETIS, T.D. (2000). Chk2=hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14, 278-288.
5. CHEN, D., YU, Z., ZHU, Z., and LOPEZ, C.D. (2008). E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair. J. Biol. Chem. 283, 15381-15389.
6. CHEN, Z., XIAO, Z., CHEN, J., NG, S.C., SOWIN, T., SHAM, H., ROSENBERG, S., FESIK, S., and ZHANG, H. (2003). Human Chk1 expression is dispensable for somatic cell death and critical for sustainingG2 DNA damage checkpoint. Mol. Cancer Ther. 2, 543-548.
7. CLARK, J.C., DASS, C.R., and CHOONG, P.F. (2008a). A review of clinical and molecular prognostic factors in osteosarcoma. J. Cancer Res. Clin. Oncol. 134, 281-297.
8. CLARK, J.C., DASS, C.R., and CHOONG, P.F. (2008b). Current and future treatments of bone metastases. Expert Opin. Emerg. Drugs 13, 609-627.
9. CUMMINGS, M., SIITONEN, T., HIGGINBOTTOM, K., NEW-LAND, A.C., and ALLEN, P.D. (2002). p53-mediated down-regulation of Chk1 abrogates the DNA damage-induced G2M checkpoint in K562 cells, resulting in increased apoptosis. Br. J. Haematol. 116, 421-428.
10. DAHAL, G.R., KARKI, P., THAPA, A., SHAHNAWAZ, M., SHIN, S.Y., LEE, J.S., CHO, B., and PARK, I.S. (2007). Caspase-2 cleaves DNA fragmentation factor (DFF45)=inhibitor of caspase-activated DNase (ICAD). Arch. Biochem. Biophys. 468, 134-139.
11. DANOVI, S.A., ROSSI, M., GUDMUNDSDOTTIR, K., YUAN, M., MELINO, G., and BASU, S. (2008). Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ. 15, 217-219.
12. DASS, C.R., and CHOONG, P.F. (2007). Zoledronic acid inhibits osteosarcoma growth in an orthotopic model. Mol. Cancer Ther. 6, 3263-3270.
13. DASS, C.R., CHOONG, P.F., and KHACHIGIAN, L.M. (2008). DNAzyme technology and cancer therapy: cleave and let die. Mol. Cancer Ther. 7, 243-251.
14. DASS, C.R., and CHOONG, P.F.M. (2010). Sequence-related off-target effect of Dz13 against human tumour cells and safety in adult and foetal mice following systemic administration. Oli-gonucleotides (In press).
15. DASS, C.R., EK, E.T., CONTRERAS, K.G., and CHOONG, P.F. (2006). A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin. Exp. Metastasis 23, 367-380.
16. DASS, C.R., FRIEDHUBE, A.M., KHACHIGIA, L.M., DUN-STAN, D.E., and CHOONG, P.F. (2008a). Biocompatible chitosan-DNAzyme nanoparticles exhibits enhanced biological activities. J. Microencapsul. 25, 421-425.
17. DASS, C.R., FRIEDHUBER, A.M., KHACHIGIAN, L.M., DUN-STAN, D.E., and CHOONG, P.F. (2008b). Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model. Cancer Biol. Ther. 7, 1033-1036.
18. DASS, C.R., GALLOWAY, S.J., CLARK, J.C., KHACHIGIAN, L.M., and CHOONG, P.F. (2008c). Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy. Cancer Biol. Ther. 7, 1297-1301.
19. DASS, C.R., KHACHIGIAN, L.M., and CHOONG, P.F. (2008d). c-Jun is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasising model. Mol. Cancer Res. 6, 1289-1292.
20. DASS, C.R., KHACHIGIAN, L.M., and CHOONG, P.F.M. (2008e). c-Jun knockdown sensitizes osteosarcoma to doxoru-bicin. Mol. Cancer Res. 7, 1909-1912.
21. DASS, C.R., SARAVOLAC, E.G., LI, Y., and SUN, L.Q. (2002). Cellular uptake, distribution and stability of 10-23 deoxyr-ibozymes. Antisense Nucleic Acid Drug Dev. 12, 289-299.
22. DEGREGORI, J., and JOHNSON, D.G. (2006). Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 6, 739-748.
23. DESCHESNES, R.G., HUOT, J., VALERIE, K., and LANDRY, J. (2001). Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol. Biol. Cell. 12, 1569-1582.
24. EJIMA, Y., and YANG, L. (1999). Determination of the genotype of a panel of human tumor cell lines for the human homologues of yeast cell cycle checkpoint control genes: identification of cell lines carrying homoallelic missense base substitutions. Somat. Cell Mol. Genet. 25, 41-48.
25. EK, E.T., DASS, C.R., CONTRERAS, K.G., and CHOONG, P.F. (2007). Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin. Exp. Metastasis 24, 93-106.
26. EMOTO, Y., KISAKI, H., MANOME, Y., KHARBANDA, S., and KUFE, D. (1996). Activation of protein kinase C delta in human myeloid leukemia cells treated with 1-beta-D-arabino-furanosylcytosine. Blood 87, 1990-1996.
27. FAHMY, R.G., DASS, C.R., SUN, L.-Q., CHESTERMAN, C.N., and KHACHIGIAN, L.M. (2003). Early growth response factor-1: a key mediator of tumour angiogenesis and neo-vascularisation. Nat. Med. 9, 1026-1032.
28. FAHMY, R.G., WALDMAN, A., ZHANG, G., MITCHELL, A., TEDLA, N., CAI, H., GECZY, C.R., CHESTERMAN, C.N., PERRY, M., and KHACHIGIAN, L.M. (2006). Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat. Biotechnol. 24, 856-863.
29. FIELD, S.J., TSAI, F.Y., KUO, F., ZUBIAGA, A.M., KAELIN, W.G., Jr., LIVINGSTON, D.M., ORKIN, S.H., and GREEN-BERG, M.E. (1996). E2F-1 functions in mice to promote apo-ptosis and suppress proliferation. Cell 85, 549-561.
30. GORDON, A.H., O'KEEFE, R.J., SCHWARZ, E.M., ROSIER, R.N., and PUZAS, J.E. (2005). Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone. Cancer Res. 65, 3209-3217.
31. IAQUINTA, P.J., and LEES, J.A. (2007). Life and death decisions by the E2F transcription factors. Curr. Opin. Cell Biol. 19, 649-657.
32. IRWIN, M.S., KONDO, K., MARIN, M.C., CHENG, L.S., HAHN, W.C., and KAELIN, W.G., Jr. (2003). Chemosensi-tivity linked to p73 function. Cancer Cell 3, 403-410.
33. KHACHIGIAN, L.M., FAHMY, R.G., ZHANG, G., BOBRYSHEV, Y.V., and KANIAROS, A. (2002). c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-Jun. J. Biol. Chem. 277, 22985-22991.
34. LOWE, S.W., RULEY, H.E., JACKS, T., and HOUSMAN, D.E. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967.
35. LUO, X., CAI, H., NI, J., BHINDI, R., LOWE, H.C., CHESTER-MAN, C.N., and KHACHIGIAN, L.M. (2009). c-Jun DNA-zymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 29, 1836-1842.
36. LUU, H.H., KANG, Q., PARK, J.K., SI, W., LUO, Q., JIANG, W., YIN, H., MONTAG, A.G., SIMON, M.A., PEABODY, T.D., HAYDON, R.C., RINKER-SCHAEFFER, C.W., and HE, T.C. (2005). An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastasis 22, 319-329.
37. MATHIEU, A.L., GONIN, S., LEVERRIER, Y., BLANQUIER, B., THOMAS, J., DANTIN, C., MARTIN, G., BAVEREL, G., and MARVEL, J. (2001). Activation of the phosphatidylinositol 3-kinase=Akt pathway protects against interleukin-3 starvation but not DNA damage-induced apoptosis. J. Biol. Chem. 276, 10935-10942.
38. MEBRATU, Y., and TESFAIGZI, Y. (2009). How ERK1=2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8, 1168-1175.
39. MITCHELL, A., DASS, C.R., SUN, L.-Q., and KHACHIGIAN, L.M. (2004). Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res. 32, 3065-3069.
40. NARASIMHAN, P., LIU, J., SONG, Y.S., MASSENGALE, J.L., and CHAN, P.H. (2009). VEGF stimulates the ERK 1=2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 40, 1467-1473.
41. PANDEY, P., RAINGEAUD, J., KANEKI, M., WEICHSEL-BAUM, R., DAVIS, R.J., KUFE, D., and KHARBANDA, S. (1996). Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and-independent mechanisms. J. Biol. Chem. 271, 23775-23779.
42. PARONI, G., HENDERSON, C., SCHNEIDER, C., and BRAN-COLINI, C. (2002). Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J. Biol. Chem. 277, 15147-15161.
43. PHILLIPS, A.C., BATES, S., RYAN, K.M., HELIN, K., and VOUSDEN, K.H. (1997). Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853-1863.
44. PICK, R., BADURA, S., BOSSER, S., and ZORNIG, M. (2006). Upon intracellular processing, the C-terminal death domain-containing fragment of the p53-inducible PIDD=LRDD protein translocates to the nucleoli and interacts with nucleolin. Bio-chem. Biophys. Res. Commun. 349, 1329-1338.
45. RIVORY, L., TUCKER, C., KING, A., LAI, A., GOODCHILD, A., WITHERINGTON, C., GOZAR, M.M., and BIRKETT, D.J. (2006). The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity. Oligonucleo-tides 16, 297-312.
46. ROGOFF, H.A., PICKERING, M.T., FRAME, F.M., DEBATIS, M.E., SANCHEZ, Y., JONES, S., and KOWALIK, T.F. (2004). Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm=Nbs1=Chk2. Mol. Cell Biol. 24, 2968-2977.
47. SAKAHIRA, H., ENARI, M., and Nagata, S. (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99.
48. SHEARWIN-WHYATT, L.M., HARVEY, N.L., and KUMAR, S. (2000). Subcellular localization and CARD-dependent oligo-merization of the death adaptor RAIDD. Cell Death Differ. 7, 155-165.
49. SHEN, Q., URAY, I.P., LI, Y., KRISKO, T.I., STRECKER, T.E., KIM, H.T., and BROWN, P.H. (2008). The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene 27, 366-377.
50. STANGELBERGER, A., SCHALLY, A.V., VARGA, J.L., ZAR-ANDI, M., CAI, R.Z., BAKER, B., HAMMANN, B.D., ARMATIS, P., and KANASHIRO, C.A. (2005). Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on ortho-topic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice. Clin. Cancer Res. 11, 49-57.
51. STEVENS, C., SMITH, L., and LA THANGUE, N.B. (2003). Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 5, 401-409.
52. TAN, M.L., CHOONG, P.F., and DASS, C.R. (2009a). Cancer, chitosan nanoparticles and catalytic nucleic acids. J. Pharm. Pharmacol. 61, 3-12.
53. TAN, M.L., CHOONG, P.F., and DASS, C.R. (2009b). DNAzyme delivery systems: getting past first base. Expert Opin. Drug Deliv. 6, 127-138.
54. TINEL, A., JANSSENS, S., LIPPENS, S., CUENIN, S., LOGETTE, E., JACCARD, B., QUADRONI, M., and TSCHOPP, J. (2007). Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J. 26, 197-208.
55. URIST, M., TANAKA, T., POYUROVSKY, M.V., and PRIVES, C. (2004). p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18, 3041-3054.
56. VAN DER KUIP, H., GOETZ, A.W., MIETHING, C., DUYSTER, J., and AULITZKY, W.E. (2001). Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis. Blood 98, 1532-1541.
57. WAXMAN, D.J., and SCHWARTZ, P.S. (2003). Harnessing apoptosis for improved anticancer gene therapy. Cancer Res. 63, 8563-8572.
58. WU, J., SUZUKI, H, ZHOU, Y.W., LIU, W., YOSHIHARA, M., KATO, M., AKHAND, A.A., HAYAKAWA, A., TAKEUCHI, K., HOSSAIN, K., KUROSAWA, M., and NAKASHIMA, I. (2001). Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines. J. Cell Biochem. 82, 200-214.
59. XIAO, Z., XUE, J., SOWIN, T.J., and ZHANG, H. (2006). Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. Mol. Cancer Ther. 5, 1935-1943.
60. YAMASAKI, L., JACKS, T., BRONSON, R., GOILLOT, E., HARLOW, E., and DYSON, N.J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
61. ZHANG, G., DASS, C.R., SUMITHRAN, E., DI GIROLAMO, N., SUN, L.Q., and KHACHIGIAN, L.M. (2004). Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J. Natl. Cancer Inst. 96, 683-696.
62. ZHANG, G., LUO, X., SUMITHRAN, E., PUA, V.S., BARNET-SON, R.S., HALLIDAY, G.M., and KHACHIGIAN, L.M. (2006). Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metallo-proteinase-2 and\9 expression. Oncogene 25, 7260-7266.
63. ZHU, J., NOZELL, S., WANG, J., JIANG, J., ZHOU, W., and CHEN, X. (2001). p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20, 4050-4057.